Growing community of inventors

Schwetzaingen, Germany

Axel Meyer

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Axel MeyerTariq Ghayur (3 patents)Axel MeyerAchim Moeller (3 patents)Axel MeyerMario Mezler (3 patents)Axel MeyerBernhard K Mueller (3 patents)Axel MeyerMartin Schmidt (3 patents)Axel MeyerNicole Teusch (3 patents)Axel MeyerReinhold Mueller (3 patents)Axel MeyerEve H Barlow (3 patents)Axel MeyerDimitris Ioannis Collias (1 patent)Axel MeyerJane Ellen Godlewski (1 patent)Axel MeyerJuan Esteban Velasquez (1 patent)Axel MeyerJanette Villalobos Lingoes (1 patent)Axel MeyerPeter Dziezok (1 patent)Axel MeyerAxel Meyer (3 patents)Tariq GhayurTariq Ghayur (38 patents)Achim MoellerAchim Moeller (30 patents)Mario MezlerMario Mezler (23 patents)Bernhard K MuellerBernhard K Mueller (21 patents)Martin SchmidtMartin Schmidt (16 patents)Nicole TeuschNicole Teusch (15 patents)Reinhold MuellerReinhold Mueller (13 patents)Eve H BarlowEve H Barlow (8 patents)Dimitris Ioannis ColliasDimitris Ioannis Collias (32 patents)Jane Ellen GodlewskiJane Ellen Godlewski (17 patents)Juan Esteban VelasquezJuan Esteban Velasquez (15 patents)Janette Villalobos LingoesJanette Villalobos Lingoes (13 patents)Peter DziezokPeter Dziezok (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Abbvie Inc. (2 from 822 patents)

2. Abb Vie Deutschland Gmbh & Co. Kg (2 from 150 patents)

3. Abbott Laboratories Corporation (1 from 4,177 patents)

4. Abbvie Deutschland Gmbh and Co Kg (17 patents)


3 patents:

1. 10040852 - Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof

2. 9255146 - Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof

3. 7906120 - Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…